Tracking the $5.1 billion the US has spent on Covid-19 medical research

With over 45,000 new cases a day, the US is very far from flattening the Covid-19 curve. But if the government came short when it comes to containing the epidemic, it is sparing no efforts in supporting medical research.

On July 6, the US government announced an investment of $1.6 billion to support pharmaceutical company Novavax in the development of 100 million doses of a Covid-19 vaccine by early 2021.

This is just the latest large investment made by the US in Covid-19 medical research: Since Feb. 11, the US government has handed out nearly $5 billion in funding, most of which is in vaccine development.

Read the rest of this story on qz.com. Become a member to get unlimited access to Quartz’s journalism.